Top pharma company ditches direct supply
AstraZenca is ditching direct supply of nine high-cost medicines, returning to exclusive distribution through wholesalers.
The decision to stop using DHL is a response to “feedback from numerous community pharmacists”, says the company.
“Everyone asked for choice, a reliable, easy way to order and access all our medicines, and this updated distribution model will address your requirements,” the company told pharmacists in a statement.
The nine brands are:
- Zoladex (goserelin acetate)
- ZolaCos (goserelin-bicalutamide)